Showing results (101-110 of 153) with videos related to
Sort By:
Pageof 16
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2024
Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attackSydney Lee, Ruth Ann Marrie, Giulia Fadda, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.CJC Open|November 1, 2021
Emergency Department Visits, Care, and Outcome After Stroke and Myocardial Infarction During the COVID-19 Pandemic PhasesAmy Y X Yu, Douglas S Lee, Manav V Vyas, et al.BMJ (Clinical Research Ed.)|July 28, 2012
Shift work and vascular events: systematic review and meta-analysisManav V Vyas, Amit X Garg, Arthur V Iansavichus, et al.CJC Open|October 18, 2022
Epidemiology of COVID-19 and Its Cardiac and Neurologic Complications Among Chinese and South Asians in Ontario: Waves 1, 2, and 3Joseph Y Chu, Gordon W Moe, Manav V Vyas, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 31, 2025
Access to Endovascular Thrombectomy: Does Driving Time to Comprehensive Stroke Center Matter More Than Rurality?Foad Taghdiri, Manav V Vyas, Moira K Kapral, et al.Journal of the American Geriatrics Society|May 5, 2021
Diagnostic accuracy of virtual cognitive assessment and testing: Systematic review and meta-analysisJennifer A Watt, Natasha E Lane, Areti Angeliki Veroniki, et al.Neurology|November 1, 2023
Association of Neighborhood Deprivation With Thrombolysis and Thrombectomy for Acute Stroke in a Health System With Universal AccessFoad Taghdiri, Manav V Vyas, Moira K Kapral, et al.Cardiology in the Young|February 24, 2021
Risk factors associated with post-transplant superior caval vein stenosis in paediatric heart transplantationHanna J Tadros, Joseph T Whelihan, Dalia Lopez-Colon, et al.Current Problems in Cardiology|October 31, 2021
Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on VorapaxarRahul Gupta, Muling Lin, Anila Mehta, et al.Pageof 16